Ledyard National Bank Gilead Sciences, Inc. Transaction History

Ledyard National Bank

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 26, 2019	SELL	$61.87 - $69.38 $313,742 - $351,825	-5,071 Closed	0 $0
Q1 2019 Apr 12, 2019	SELL	$62.53 - $70.05 $473,664 - $530,628	-7,575 Reduced 59.9%	5,071 $330,000
Q4 2018 Jan 29, 2019	SELL	$60.54 - $79.0 $24,821 - $32,390	-410 Reduced 3.14%	12,646 $791,000
Q3 2018 Oct 24, 2018	SELL	$71.28 - $78.92 $27,799 - $30,778	-390 Reduced 2.9%	13,056 $1.01 Million
Q2 2018 Jul 11, 2018	SELL	$64.88 - $75.68 $20,372 - $23,763	-314 Reduced 2.28%	13,446 $953,000
Q1 2018 Apr 16, 2018	SELL	$72.84 - $88.8 $38,605 - $47,064	-530 Reduced 3.71%	13,760 $1.04 Million
Q4 2017 Jan 30, 2018	BUY	$71.15 - $83.52 $246,534 - $289,396	3,465 Added 32.01%	14,290 $1.02 Million
Q3 2017 Oct 10, 2017	BUY	$72.11 - $85.47 $780,590 - $925,212	10,825	10,825 $877,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Ledyard National Bank, based on Form 13F filings with the SEC.

Stay updated on Ledyard National Bank with notifications on news.